Tamás Masszi
Semmelweis University(HU)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Protein Degradation and Inhibitors, Myeloproliferative Neoplasms: Diagnosis and Treatment
Most-Cited Works
- → Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma(2016)1,500 cited
- → Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma(2014)1,316 cited
- → Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma(2016)1,044 cited
- → Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera(2015)858 cited
- → Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study(2015)836 cited
- → Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial(2015)727 cited
- → Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study(2015)534 cited
- → Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation(2016)514 cited
- → Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis(2015)455 cited
- → Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives—a position statement from the European Society for Blood and Marrow Transplantation (EBMT)(2015)378 cited